Hemostasis Rapid Tests & Point of Care (POC) - Global Medical Devices Pipeline Assessment, 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.

This report provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products.

Scope

  • Extensive coverage of the Hemostasis Rapid Tests & Point of Care (POC) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hemostasis Rapid Tests & Point of Care (POC) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hemostasis Rapid Tests & Point of Care (POC) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Hemostasis Rapid Tests & Point of Care (POC) Overview

3 Products under Development

3.1 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development

3.2 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Territory

3.3 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Regulatory Path

3.4 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Estimated Approval Date

4 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products under Development by Companies

4.1 Hemostasis Rapid Tests & Point of Care (POC) Companies - Pipeline Products by Stage of Development

4.2 Hemostasis Rapid Tests & Point of Care (POC) Pipeline Products by Stage of Development

5 Hemostasis Rapid Tests & Point of Care (POC) Companies and Product Overview

  • Company Overview
  • Pipeline Products & Ongoing Clinical Trials Overview

5.1 Atomo Diagnostics Pty. Ltd.

5.1.1 Atomo Diagnostics Pty. Ltd.

5.2 Carclo Diagnostic Solutions Ltd.

5.3 Cascade Metrix LLC

5.4 Edan Instruments Inc.

5.5 EKF Diagnostics Holdings PLC

5.6 Emosis SAS

5.7 Fraunhofer Institute for Cell Therapy and Immunology

5.8 Helena Laboratories Corp.

5.9 Universal Biosensors Inc.

6 Hemostasis Rapid Tests & Point of Care (POC) - Recent Developments

6.1 Apr 08, 2019: Aggredyne receives FDA clearance for ADP platelet aggregation testing cartridge

6.2 Nov 22, 2018: EMOSIS reinforces its Intellectual Property and scientific expertise

For more information about this report visit https://www.researchandmarkets.com/r/kb28jf

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900